Galera Therapeutics Inc Ordinary Shares (NASDAQ:GRTX)

North American company
add to virtual portfolio
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - GRTX

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - GRTX

  • Market Cap$224.760m
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINUS36338D1081

Company Profile

Galera Therapeutics Inc is a biopharmaceutical company focused on developing therapeutics that have the potential to transform radiotherapy in cancer. Its lead product candidate, GC4419, is a small molecule dismutase mimetic developed for the reduction of severe oral mucositis, or SOM.

Latest GRTX news

Currently there for this company. Visit our news hub for other news .